Pancreatic Cancer Research

ResearcherNational Defense Medical College HospitalActive in the last 2 years

Kazuki Kobayashi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9365-9490; OpenAlex author ID A5110479340. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2024: 2 papers · 2025: 7 papers

Papers 9

  1. Risk of hepatic steatosis with the preoperative treatment of pancreatic cancer and the short-term postoperative outcomes. Co-author DOI 10.1007/s00595-024-02895-x↗
  2. Prognostic impact of dose reduced S-1 adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: a retrospective multicenter study. Co-author DOI 10.1007/s10147-025-02742-0↗
  3. Postoperative recurrence of pancreatic cancer controlled for 9 months solely by severe carbohydrate restriction: ketogenic diet. Co-author DOI 10.1007/s12328-025-02221-z↗
  4. Surgery based on resectability status of pancreatic cancer: a narrative review. Co-author DOI 10.1093/jjco/hyaf131↗
  5. Dissecting Tumor Size Underestimation in Pancreatic Cancer: A Comparative Analysis of Preoperative Treatments. Co-author DOI 10.1245/s10434-025-16917-6↗
  6. ASO Author Reflections: Reshaping Tumor Size through Insights from Pancreatic Cancer Imaging and Pathology. Co-author DOI 10.1245/s10434-025-16983-w↗
  7. Reply to: Letter to the Editor of Annals of Surgical Oncology Concerning "Dissecting Tumor Size Underestimation in Pancreatic Cancer: A Comparative Analysis of… Co-author DOI 10.1245/s10434-025-17816-6↗
  8. Preoperative CA19‑9 level and dual time point FDG‑PET/CT as strong biological indicators of borderline resectability in pancreatic cancer: A retrospective stud… Co-author DOI 10.3892/ol.2024.14412↗
  9. Pancreatic cancer with liver metastasis maintaining complete response with gemcitabine monotherapy: A case report. Co-author DOI 10.3892/ol.2024.14503↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoji Kishi · 9 shared papers, 2024–2025 · strength 2.67
  2. Takahiro Einama · 7 shared papers, 2024–2025 · strength 1.60
  3. Hideki Ueno · 6 shared papers, 2024–2025 · strength 1.38
  4. Mayuko Ohara · 2 shared papers, 2024–2025 · strength 0.43
  5. Koki Ichio · 2 shared papers, 2024–2025 · strength 0.43
  6. Yoshifumi Beck · 1 shared paper, 2025 · strength 0.22
  7. Yoichi Miyata · 1 shared paper, 2025 · strength 0.22
  8. Makoto Nishikawa · 1 shared paper, 2025 · strength 0.22
  9. Akifumi Kimura · 1 shared paper, 2025 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.